Augmented Macular Pigment-containing Nutraceutical and Central Visual Function

Exclusion Criteria

• •BCVA worse than 20/200
• •Pt Is unable to tolerate MPOD, CS, dermal carotenoid measurement-taking procedures
• •Loss of IOP control requires surgical intervention
• •Patient already taking AREDS formula oral supplement
• •Patient taking medication or dietary supplements that may interact with LM ingredients
• •History of photosensitive epilepsy
• •History of penetrating ocular trauma or vitrectomy
• •History of ocular or orbital radiation therapy or is currently receiving chemotherapy
• •Women who are nursing, pregnant, or are planning pregnancy
• •Has a known adverse reaction (including sulfa allergy) and/or sensitivity to the study supplement or its ingredients including: N-acetyl-cysteine, acetyl-L-carnitine, L-taurine, quercetin, Co-enzyme Q-10, lutein, meso zeaxanthin, zeaxanthin, astazanthin, lycopene, alpha-lipoic acid.
• •Currently enrolled in an investigational drug study or has used an investigational drug within 30 days prior to recruitment.
• •Is planning on having ocular surgery at any time throughout the study duration, or had ocular surgery \< 3 months before enrollment
• •Native lens opacity ≥ grade 3 on ARLNS standard photograph
• •Blue light filter intraocular lens